252 related articles for article (PubMed ID: 22374465)
1. Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.
Yamamoto K; Ohga N; Hida Y; Maishi N; Kawamoto T; Kitayama K; Akiyama K; Osawa T; Kondoh M; Matsuda K; Onodera Y; Fujie M; Kaga K; Hirano S; Shinohara N; Shindoh M; Hida K
Br J Cancer; 2012 Mar; 106(6):1214-23. PubMed ID: 22374465
[TBL] [Abstract][Full Text] [Related]
2. Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.
Maishi N; Ohba Y; Akiyama K; Ohga N; Hamada J; Nagao-Kitamoto H; Alam MT; Yamamoto K; Kawamoto T; Inoue N; Taketomi A; Shindoh M; Hida Y; Hida K
Sci Rep; 2016 Jun; 6():28039. PubMed ID: 27295191
[TBL] [Abstract][Full Text] [Related]
3. CXCR7: a novel tumor endothelial marker in renal cell carcinoma.
Maishi N; Ohga N; Hida Y; Akiyama K; Kitayama K; Osawa T; Onodera Y; Shinohara N; Nonomura K; Shindoh M; Hida K
Pathol Int; 2012 May; 62(5):309-17. PubMed ID: 22524658
[TBL] [Abstract][Full Text] [Related]
4. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
[TBL] [Abstract][Full Text] [Related]
5. Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.
Maishi N; Sakurai Y; Hatakeyama H; Umeyama Y; Nakamura T; Endo R; Alam MT; Li C; Annan DA; Kikuchi H; Morimoto H; Morimoto M; Akiyama K; Ohga N; Hida Y; Harashima H; Hida K
Cancer Sci; 2022 May; 113(5):1855-1867. PubMed ID: 35266253
[TBL] [Abstract][Full Text] [Related]
6. The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.
Akiyama K; Ohga N; Maishi N; Hida Y; Kitayama K; Kawamoto T; Osawa T; Suzuki Y; Shinohara N; Nonomura K; Shindoh M; Hida K
Pathol Int; 2013 Jan; 63(1):37-44. PubMed ID: 23356224
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis.
Osawa T; Ohga N; Akiyama K; Hida Y; Kitayama K; Kawamoto T; Yamamoto K; Maishi N; Kondoh M; Onodera Y; Fujie M; Shinohara N; Nonomura K; Shindoh M; Hida K
Br J Cancer; 2013 Oct; 109(8):2237-47. PubMed ID: 24045659
[TBL] [Abstract][Full Text] [Related]
8. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.
Kurosu T; Ohga N; Hida Y; Maishi N; Akiyama K; Kakuguchi W; Kuroshima T; Kondo M; Akino T; Totsuka Y; Shindoh M; Higashino F; Hida K
Br J Cancer; 2011 Mar; 104(5):819-29. PubMed ID: 21285980
[TBL] [Abstract][Full Text] [Related]
9. ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells.
Hojo T; Maishi N; Towfik AM; Akiyama K; Ohga N; Shindoh M; Hida Y; Minowa K; Fujisawa T; Hida K
Oncotarget; 2017 Jul; 8(28):45484-45495. PubMed ID: 28525375
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.
Osawa T; Ohga N; Hida Y; Kitayama K; Akiyama K; Onodera Y; Fujie M; Shinohara N; Shindoh M; Nonomura K; Hida K
Cancer Sci; 2012 Jun; 103(6):1038-44. PubMed ID: 22380928
[TBL] [Abstract][Full Text] [Related]
11. Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype.
Ohmura-Kakutani H; Akiyama K; Maishi N; Ohga N; Hida Y; Kawamoto T; Iida J; Shindoh M; Tsuchiya K; Shinohara N; Hida K
PLoS One; 2014; 9(12):e113910. PubMed ID: 25437864
[TBL] [Abstract][Full Text] [Related]
12. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.
Xiong YQ; Sun HC; Zhang W; Zhu XD; Zhuang PY; Zhang JB; Wang L; Wu WZ; Qin LX; Tang ZY
Clin Cancer Res; 2009 Aug; 15(15):4838-46. PubMed ID: 19638466
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.
Tsuchiya K; Hida K; Hida Y; Muraki C; Ohga N; Akino T; Kondo T; Miseki T; Nakagawa K; Shindoh M; Harabayashi T; Shinohara N; Nonomura K; Kobayashi M
Int J Oncol; 2010 Jun; 36(6):1379-86. PubMed ID: 20428760
[TBL] [Abstract][Full Text] [Related]
14. Tumor endothelial cell-derived cadherin-2 promotes angiogenesis and has prognostic significance for lung adenocarcinoma.
Zhuo H; Zhao Y; Cheng X; Xu M; Wang L; Lin L; Lyu Z; Hong X; Cai J
Mol Cancer; 2019 Mar; 18(1):34. PubMed ID: 30832661
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells.
Otsubo T; Hida Y; Ohga N; Sato H; Kai T; Matsuki Y; Takasu H; Akiyama K; Maishi N; Kawamoto T; Shinohara N; Nonomura K; Hida K
Cancer Sci; 2014 May; 105(5):560-7. PubMed ID: 24602018
[TBL] [Abstract][Full Text] [Related]
16. Isolated tumor endothelial cells maintain specific character during long-term culture.
Matsuda K; Ohga N; Hida Y; Muraki C; Tsuchiya K; Kurosu T; Akino T; Shih SC; Totsuka Y; Klagsbrun M; Shindoh M; Hida K
Biochem Biophys Res Commun; 2010 Apr; 394(4):947-54. PubMed ID: 20302845
[TBL] [Abstract][Full Text] [Related]
17. Suprabasin as a novel tumor endothelial cell marker.
Alam MT; Nagao-Kitamoto H; Ohga N; Akiyama K; Maishi N; Kawamoto T; Shinohara N; Taketomi A; Shindoh M; Hida Y; Hida K
Cancer Sci; 2014 Dec; 105(12):1533-40. PubMed ID: 25283635
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer.
Niedworok C; Röck K; Kretschmer I; Freudenberger T; Nagy N; Szarvas T; Vom Dorp F; Reis H; Rübben H; Fischer JW
PLoS One; 2013; 8(11):e80084. PubMed ID: 24223213
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.
Muraki C; Ohga N; Hida Y; Nishihara H; Kato Y; Tsuchiya K; Matsuda K; Totsuka Y; Shindoh M; Hida K
Int J Cancer; 2012 Jan; 130(1):59-70. PubMed ID: 21384343
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of biglycan expression by RNA interference inhibits the proliferation and invasion of, and induces apoptosis in, the HCT116 colon cancer cell line.
Xing X; Gu X; Ma T
Mol Med Rep; 2015 Nov; 12(5):7538-44. PubMed ID: 26459740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
